In 2023, the death rate from HIV was highest among African Americans, with around 18 deaths per 100,000 population. This statistic shows the death rate from HIV in the U.S. in 2023, by race and ethnicity, per 100,000 population.

In 2023, there were *** male deaths from the HIV disease per 100,000 inhabitants in the United States. This statistic shows the death rate for the human immunodeficiency virus (HIV) disease among the U.S. population from 1987 to 2023, by gender.

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

In 2022, the District of Columbia had the highest HIV disease death rate among all U.S. states where 6.2 out of 100,000 inhabitants died due to HIV in 2022. This statistic shows the U.S. states with the highest HIV disease death rates in 2022.

This dataset contains death counts, crude rates and adjusted rates for selected causes of death by county and region. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

This scatter chart displays death rate (per 1,000 people) against incidence of HIV (per 1,000 uninfected population). The data is about regions.

The mortality estimate methodology is fully described elsewhere and takes into consideration parameters such as ART coverage. For example, HIV associated mortality in Mozambique also reflects injection drug user driven epidemic.ART coverage calculated using 2013 reported people on ART/people estimated to be living with HIV in 2013.** Published guidelines as of December 2014; WHO 2013 Guidelines recommend

In 2024, South Africa and Mozambique had the highest number of deaths due to AIDS worldwide, with around ** thousand and ** thousand such deaths, respectively. African countries account for eight of the top 10 countries with the highest number of AIDS-related deaths worldwide. AIDS-related deaths worldwide have been gradually declining over the past decade, decreasing from *** million deaths in 2010 to *** thousand deaths in 2024. HIV/AIDS HIV (human immunodeficiency virus) is an infectious sexually transmitted disease that is transmitted via exposure to infected semen, blood, vaginal and anal fluids and breast milk. HIV weakens the human immune system, resulting in the affected person being unable to fight off opportunistic infections. The top 15 countries worldwide with the highest prevalence of new HIV infections as of 2024 were all African. HIV treatment Although there is currently no effective cure for HIV, death can be prevented by taking HIV antiretroviral therapy (ART). Access to antiretroviral therapy worldwide has significantly increased in the past decade. As of 2024, around **** million people with HIV worldwide were receiving ART. The countries with the highest percentage of HIV-infected children who were receiving ART were Eswatini, Kenya, and Lesotho.

In 2019, HIV-AIDS Mortality in South Africa rose 2.6% from a year earlier.

This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by December 31, 2024, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

This dataset contains death counts and crude rates by region, age group, and selected cause of death. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

Death rate of a population adjusted to a standard age distribution. As most causes of death vary significantly with people's age and sex, the use of standardised death rates improves comparability over time and between countries, as they aim at measuring death rates independently of different age structures of populations. The standardised death rates used here are calculated on the basis of a standard European population (defined by the World Health Organization). Detailed data for 65 causes of death are available in the database (under the heading 'Data').

This scatter chart displays incidence of HIV (per 1,000 uninfected population) against death rate (per 1,000 people) in the Americas. The data is about regions.

Forecast: HIV-AIDS Mortality in the UK 2023 - 2027 Discover more data with ReportLinker!

This scatter chart displays death rate (per 1,000 people) against incidence of HIV (per 1,000 uninfected population). The data is about countries.

Mortality rates overall, and for AIDS-related and non-AIDS related causes of death over calendar periods.

This scatter chart displays death rate (per 1,000 people) against incidence of HIV (per 1,000 uninfected population) in Europe. The data is about countries.

Forecast: HIV-AIDS Mortality in the US 2023 - 2027 Discover more data with ReportLinker!

Average number IDU living with AIDS, number of AIDS deaths, and AIDS mortality rates of IDUs living with AIDS per 10,000 adult population (age 15–64) in 86 large metropolitan statistical areas in the USA 1993–1995 (Pre-HAART) and 2004–2006 (HAART era), and the AIDS mortality rate ratio between late and early years.

UNAIDS estimated that there were some ******* people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2024. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2024. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2024, the highest number of AIDS-related deaths occurred in South Africa and Mozambique and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost ** million in 2024. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.